Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 1, 2011, Pages 110-115

  Al Mutairi, N M ^a   Ahmad, Suhail ^a   Mokaddas, E ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Isoniazid; Molecular detection; Multidrug resistance; Mycobacterium tuberculosis; Rifampicin

Indexed keywords

BACTERIAL DNA; ISONIAZID; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL LABORATORY; DEVICE; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RPOB GENE; SPUTUM CULTURE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CATALASE; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; KUWAIT; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 78650161157     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
2. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
3. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 2009; 103: 1777-1790.
4. Chiang C-Y, Yew W W. Multidrug-resistant and extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009; 13: 304-311.
5. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae and other aerobic actinomycetes: approved standard. Wayne, PA, USA: NCCLS, 2003.
6. Drobniewski F A, Caws M, Gibson A, Young D. Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis 2003; 3: 141-147.
7. Mokaddas E, Ahmad S, Samir I. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005. Int J Tuberc Lung Dis 2008; 12: 319-325.
8. Golden M P, Vikram H R. Extra-pulmonary tuberculosis: an overview. Am Fam Phys 2005; 72: 1761-1768.
9. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650.
10. Zhang Y, Yew W W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1320-1330.
11. Heep M, Brandstatter B, Rieger U, et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 107-110.
12. Wang Q, Yue J, Zhang L, et al. A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis. J Proteome Res 2007; 6: 4564-4571.
13. Zhang Y, Heym B, Allen B, Young D, Cole S T. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992; 358: 591-593.
14. Abal A T, Ahmad S, Mokaddas E. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb Drug Resist 2002; 8: 99-105.
15. Ramaswamy S, Reich R, Dou S, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 1241-1250.
16. Hazbon M H, Brimacombe M, del Valle M B, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006; 50: 2640-2649.
17. Quezada C M, Kamanzi E, Mukamutara J, et al. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line-probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol 2007; 45: 3111-3114.
18. Kimerling M E, Phillips P, Patterson P, Hall M, Robinson C A, Dunlap N E. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest 1998; 113: 1178-1183. (Pubitemid 28223801)
19. Mokaddas E, Ahmad S, Abal A T, Al-Shami A S. Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait. Ann Saudi Med 2005; 25: 150-153. (Pubitemid 40667731)
20. Hillemann D, Gerdes R S, Richter E. Evaluation of GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640.
21. Causse M, Ruiz P, Gutierrez J B, Zerolo J, Casal M. Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2008; 12: 1456-1460.
22. Vijdea R, Stegger M, Sosnovskaja A, Andersen A B, Thomsen V O, Bang D. Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of resistance in clinical specimens and isolates. Eur J Clin Microbiol Infect Dis 2008; 27: 1079-1086.
23. Hauck Y, Fabre M, Vergnaud G, Soler C, Pourcel C. Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. J Antimicrob Chemother 2009; 64: 259-262.
24. Nikolayevsky V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F. Performance of GenoType MTBDR-plus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin Pathol 2009; 9: 2.
25. Ahmad S, Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005; 26: 205-212.
26. Ahmad S, Mokaddas E. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. Int J Antimicrob Agents 2004; 23: 473-479.
27. Evans J, Stead M C, Nicol M P, Segal H. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J Antimicrob Chemother 2009; 63: 11-16.
28. Huang W L, Chen H Y, Kuo Y M, Jou R. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2009; 47: 2520-2524.
29. Ahmad S, Mokaddas E, Fares E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai. Diagn Microbiol Infect Dis 2002; 44: 245-252.
30. Yuen L K W, Leslie D, Coloe P J. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J Clin Microbiol 1999; 37: 3844-3850.
31. Van Deun A, Barrera L, Bastian I, et al. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol 2009; 47: 3501-3506.
32. Huang H, Jin Q, Ma Y, Chen X, Zhuang Y. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates in China. Tuberculosis 2002; 82: 79-83.
33. Cooksey R C, Morlock G P, Glickman S, Crawford J T. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997; 35: 1281-1283.
34. Kapur V, Li L-L, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095-1098.
35. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 1999; 37: 2663-2666.